Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A | P62942 | 16/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3656325 | 0.96 | FKBP1A (0.48) | FKBP1ARAB9ANPC1POLBLMNA | |
| SCHEMBL5727740 | 0.96 | FKBP1A (0.48) | FKBP1ARAB9ANPC1POLBLMNA | |
| SCHEMBL8141816 | 0.96 | FKBP1A (0.48) | FKBP1ARAB9ANPC1POLBLMNA | |
| SCHEMBL20124968 | 0.89 | FKBP1A (0.55) | FKBP1ARAB9A | |
| SCHEMBL695607 | 0.87 | FKBP1A (0.51) | FKBP1ARAB9APOLBLMNASMN1; SMN2 | |
| SCHEMBL19334646 | 0.87 | FKBP1A (0.50) | FKBP1ARAB9APOLBLMNASMN1; SMN2 | |
| SCHEMBL7815566 | 0.86 | RAB9A (0.57) | FKBP1ARAB9APOLBLMNASMN1; SMN2 | |
| SCHEMBL7811720 | 0.86 | RAB9A (0.57) | FKBP1ARAB9APOLBLMNASMN1; SMN2 | |
| SCHEMBL3710312 | 0.86 | RAB9A (0.57) | FKBP1ARAB9APOLBLMNASMN1; SMN2 | |
| SCHEMBL16400426 | 0.85 | NPSR1 (0.43) | FKBP1ARAB9APOLBLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8288606-B2 | Magnesium, titanium, and halogen; internal electron donor, ethyl N-Boc-sarcosine, ethyl N-propionyl sarcosine, ethyl N-Boc-pipercolinate, N-carbobenzyloxy-L-proline methyl ester; polymerize propylene and ethylene or alpha-olefin; internal modifier which does not contain a phthalate derivative | INEOS USA LLC (US) | 2012-10-16 | — | — | US | disclosed |
| US-20080125614-A1 | Propylene polymer catalyst donor component | INNOVENE USA (US) | 2008-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080125614-A1 | Propylene polymer catalyst donor component | RAD52, PGR, DRD2 | FKBP1A 1570/4885RAB9A 4584/4885NPC1 3629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.